v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2025   232,888      
Beginning balance at Jan. 31, 2025 $ 227,523 $ 2 $ 2,059,848 $ (3,851) $ (1,828,476)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of stock options (in shares)   593      
Issuance of common stock upon the exercise of stock options 2,073   2,073    
Repurchases and retirement of common stock (in shares)   (2,992)      
Repurchases and retirement of common stock (43,398)       (43,398)
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)   5,105      
Issuance of common stock upon the vesting and settlement of restricted stock units 0        
Issuance of common stock under employee share purchase plan (in shares)   751      
Issuance of common stock under employee share purchase plan 7,746   7,746    
Stock-based compensation expense 113,876   113,876    
Net unrealized (losses) gains on marketable securities 120     120  
Foreign currency translation adjustments 4,994     4,994  
Net loss (88,378)       (88,378)
Ending balance (in shares) at Jul. 31, 2025   236,345      
Ending balance at Jul. 31, 2025 224,556 $ 2 2,183,543 1,263 (1,960,252)
Beginning balance (in shares) at Apr. 30, 2025   235,220      
Beginning balance at Apr. 30, 2025 236,304 $ 2 2,118,447 1,955 (1,884,100)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of stock options (in shares)   239      
Issuance of common stock upon the exercise of stock options 816   816    
Repurchases and retirement of common stock (in shares)   (1,958)      
Repurchases and retirement of common stock (27,792)       (27,792)
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)   2,844      
Stock-based compensation expense 64,280   64,280    
Net unrealized (losses) gains on marketable securities (944)     (944)  
Foreign currency translation adjustments 252     252  
Net loss (48,360)       (48,360)
Ending balance (in shares) at Jul. 31, 2025   236,345      
Ending balance at Jul. 31, 2025 224,556 $ 2 2,183,543 1,263 (1,960,252)
Beginning balance (in shares) at Jan. 31, 2026   237,915      
Beginning balance at Jan. 31, 2026 $ 154,117 $ 2 2,299,616 4,205 (2,149,706)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of stock options (in shares) 530 530      
Issuance of common stock upon the exercise of stock options $ 1,340   1,340    
Repurchases and retirement of common stock (in shares)   (14,813)      
Repurchases and retirement of common stock (96,526)       (96,526)
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)   6,224      
Issuance of common stock upon the vesting and settlement of restricted stock units 0        
Issuance of common stock under employee share purchase plan (in shares)   818      
Issuance of common stock under employee share purchase plan 4,874   4,874    
Stock-based compensation expense 97,626   97,626    
Net unrealized (losses) gains on marketable securities (1,410)     (1,410)  
Foreign currency translation adjustments (2,104)     (2,104)  
Net loss (53,594)       (53,594)
Ending balance (in shares) at Jul. 31, 2026   230,674      
Ending balance at Jul. 31, 2026 104,323 $ 2 2,403,456 691 (2,299,826)
Beginning balance (in shares) at Apr. 30, 2026   233,901      
Beginning balance at Apr. 30, 2026 136,982 $ 2 2,343,418 2,658 (2,209,096)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of stock options (in shares)   250      
Issuance of common stock upon the exercise of stock options 654   654    
Repurchases and retirement of common stock (in shares)   (7,445)      
Repurchases and retirement of common stock (51,541)       (51,541)
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)   3,968      
Stock-based compensation expense 59,384   59,384    
Net unrealized (losses) gains on marketable securities (401)     (401)  
Foreign currency translation adjustments (1,566)     (1,566)  
Net loss (39,189)       (39,189)
Ending balance (in shares) at Jul. 31, 2026   230,674      
Ending balance at Jul. 31, 2026 $ 104,323 $ 2 $ 2,403,456 $ 691 $ (2,299,826)